Contact JoDrugs
Contact Us
|
Feedback
FULL VIEW
Drug. / Keyword
☰ Menu
Drugs
Drugs In Jordan
Drugs In USA
Look Alike Sound Alike
Drug Classes
JoDrug Blog
Manufacturers
Calculators
Contact Us
Critical Care - Intracranial Bleeding Risk from Thrombolytic Therapy of MI
Critical Care
,
Heart and Chest
,
Brain and Spinal Cord
Like
Tweet
Google+
Intracranial Bleeding Risk from Thrombolytic Therapy of MI
Select Criteria:
Patient 75 years old or older (1 point)
Patient of Black race (1 point)
Patient is female (1 point)
Prior history of stroke (1 point)
Systolic BP >= 160 mmHg (1 point)
Body weight less <= 65 Kg for women, <= 80 Kg for men (1 point)
INR > 4 or prothrombin time > 24 seconds (1 point)
TPA used instead of another thrombolytic (1 point)
Results:
Total Criteria Point Count:
Risk of Cerebral Bleeding
0-1 points:
0.69% Risk
2 points:
1.02% Risk
3 points:
1.63% Risk
4 points:
2.49% Risk
5-8 points:
4.11% Risk
References
Brass LM, Lichtman JH, Wang Y, et al. Intracranial hemorrhage associated with thrombolytic therapy for elderly patients with acute myocardial infarction.
Stroke
. 2000; 31: 1802-11.
Legal Notices and Disclaimer
All information contained in and produced by JoDrugs is provided for educational purposes only. This information should not be used for the diagnosis or treatment of any health problem or disease.
THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER.
Click here for full notice and disclaimer.